Alphatec (US:ATEC) ZACKS·2025-05-01 23:06Company Performance - Alphatec reported a quarterly loss of $0.23 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.12, representing an earnings surprise of -91.67% [1] - The company posted revenues of $169.18 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.23%, and showing an increase from $138.48 million year-over-year [2] - Over the last four quarters, Alphatec has not been able to surpass consensus EPS estimates, although it has topped consensus revenue estimates four times [2] Stock Outlook - Alphatec shares have increased by approximately 19.6% since the beginning of the year, contrasting with the S&P 500's decline of -5.3% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.06 on revenues of $179.11 million, and for the current fiscal year, it is -$0.25 on revenues of $733.31 million [7] Industry Context - The Medical - Instruments industry, to which Alphatec belongs, is currently ranked in the top 23% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Alphatec's stock performance [5]